RAC 3.31% $1.61 race oncology ltd

Ann: RC220 Peripheral Infusion Safety Confirmed, page-18

  1. 342 Posts.
    lightbulb Created with Sketch. 94
    I reckon big pharma would be happy to buy now. This has de-risked RACE hugely.

    Are there any other steps we need to take for RC220 to be used in human trials (approvals etc)?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.